MICHAEL JOHNSON

Concepts (443)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dementia
15
2021
487
2.390
Why?
Medicare
20
2025
463
2.040
Why?
Comparative Effectiveness Research
5
2012
77
1.380
Why?
Hypertension
10
2023
1396
1.330
Why?
Aged
89
2025
21608
1.260
Why?
Retrospective Studies
71
2025
17382
1.250
Why?
Angiotensin-Converting Enzyme Inhibitors
6
2023
226
1.240
Why?
United States
68
2025
11677
1.230
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
7
2022
757
1.190
Why?
Protein Kinase Inhibitors
3
2023
610
1.150
Why?
Heart Failure
17
2016
2421
1.070
Why?
Breast Neoplasms
5
2023
2763
1.030
Why?
SEER Program
3
2024
224
1.000
Why?
Antipsychotic Agents
12
2021
388
0.990
Why?
Practice Patterns, Physicians'
8
2018
765
0.990
Why?
Diabetes Mellitus, Type 2
7
2025
1405
0.970
Why?
Risk
14
2017
833
0.950
Why?
Angiotensin Receptor Antagonists
5
2023
138
0.940
Why?
United States Department of Veterans Affairs
10
2012
703
0.930
Why?
Cholinergic Antagonists
7
2019
54
0.880
Why?
Proportional Hazards Models
11
2019
1484
0.870
Why?
Prescription Drugs
5
2019
58
0.840
Why?
Antihypertensive Agents
5
2012
410
0.800
Why?
Diabetes Mellitus
13
2023
931
0.790
Why?
Autoimmune Diseases
1
2024
276
0.750
Why?
Aged, 80 and over
33
2024
7160
0.730
Why?
Economics, Pharmaceutical
3
2009
9
0.730
Why?
Hospitals, Veterans
17
2007
357
0.730
Why?
Motivational Interviewing
4
2023
52
0.710
Why?
Databases, Factual
11
2024
1241
0.710
Why?
Comorbidity
16
2020
1616
0.690
Why?
Depression
12
2020
1356
0.690
Why?
Urinary Bladder, Overactive
4
2021
31
0.680
Why?
Hyperlipidemias
4
2022
198
0.680
Why?
Metformin
1
2022
162
0.680
Why?
Female
87
2025
71463
0.680
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
377
0.680
Why?
Cohort Studies
29
2022
5176
0.660
Why?
Selection Bias
2
2009
22
0.650
Why?
Humans
123
2025
133421
0.640
Why?
Nursing Homes
11
2019
97
0.630
Why?
Cardiovascular Diseases
6
2023
2087
0.630
Why?
Male
84
2025
65693
0.610
Why?
Dyslipidemias
2
2015
244
0.590
Why?
Risk Adjustment
5
2015
60
0.590
Why?
Protein-Tyrosine Kinases
1
2019
231
0.560
Why?
Medicare Part C
5
2023
39
0.550
Why?
Risk Assessment
8
2016
3696
0.550
Why?
Medicare Part D
4
2020
17
0.540
Why?
Epidemiologic Research Design
1
2016
8
0.520
Why?
Paroxetine
4
2017
29
0.510
Why?
Lung Neoplasms
2
2024
1787
0.500
Why?
Proton Pump Inhibitors
1
2019
285
0.490
Why?
Middle Aged
51
2025
29212
0.490
Why?
Veterans
11
2011
1766
0.480
Why?
Gastroesophageal Reflux
1
2019
336
0.480
Why?
Odds Ratio
5
2016
1336
0.470
Why?
Receptor, ErbB-2
3
2023
559
0.460
Why?
Multivariate Analysis
14
2016
1488
0.450
Why?
Medication Adherence
7
2025
338
0.450
Why?
Longitudinal Studies
7
2021
1493
0.430
Why?
Drug Utilization Review
3
2019
33
0.420
Why?
Logistic Models
16
2017
1907
0.400
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2023
1349
0.400
Why?
Managed Care Programs
3
2022
61
0.400
Why?
Cyclin-Dependent Kinase 4
2
2023
67
0.390
Why?
Hypoglycemic Agents
3
2025
480
0.390
Why?
Anti-Obesity Agents
1
2012
45
0.380
Why?
Antirheumatic Agents
2
2023
124
0.370
Why?
Losartan
1
2011
36
0.360
Why?
Biphenyl Compounds
1
2011
62
0.360
Why?
Tetrazoles
1
2011
64
0.360
Why?
Valine
1
2011
116
0.350
Why?
Pneumonia
3
2020
342
0.340
Why?
Benzimidazoles
1
2011
136
0.340
Why?
Case-Control Studies
14
2023
3642
0.340
Why?
Arthritis, Rheumatoid
2
2023
294
0.330
Why?
Insurance, Pharmaceutical Services
1
2009
10
0.320
Why?
Neoplasms
3
2020
3024
0.320
Why?
Quality Indicators, Health Care
3
2019
232
0.320
Why?
Guidelines as Topic
1
2011
201
0.320
Why?
Angioplasty
2
2007
80
0.310
Why?
Risk Factors
23
2017
11084
0.310
Why?
Survival Rate
5
2023
2210
0.310
Why?
Pharmaceutical Services
1
2009
38
0.310
Why?
Incidence
15
2019
3396
0.300
Why?
Data Interpretation, Statistical
4
2011
239
0.300
Why?
Aortic Aneurysm, Abdominal
4
2007
444
0.300
Why?
Baths
2
2020
16
0.300
Why?
Elective Surgical Procedures
3
2007
168
0.290
Why?
Multiple Sclerosis
2
2023
392
0.290
Why?
Propensity Score
7
2017
258
0.290
Why?
Research
3
2023
272
0.290
Why?
Anti-Infective Agents, Local
2
2020
69
0.280
Why?
Health Expenditures
3
2018
116
0.280
Why?
Prescription Drug Monitoring Programs
2
2017
9
0.280
Why?
Treatment Outcome
13
2023
12973
0.280
Why?
Accidental Falls
3
2016
120
0.280
Why?
Drug Utilization
3
2020
166
0.270
Why?
Diuretics
2
2005
169
0.270
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2006
315
0.270
Why?
Healthcare Disparities
1
2012
479
0.270
Why?
Leptospirosis
1
2006
6
0.270
Why?
Cholinesterase Inhibitors
3
2022
102
0.260
Why?
Quality of Health Care
5
2005
420
0.260
Why?
Fractures, Bone
3
2016
212
0.260
Why?
Drug-Related Side Effects and Adverse Reactions
4
2017
284
0.260
Why?
Dog Diseases
1
2006
60
0.250
Why?
Varenicline
2
2016
14
0.250
Why?
Data Collection
3
2016
396
0.250
Why?
Bupropion
2
2016
30
0.250
Why?
Antidepressive Agents, Second-Generation
2
2016
38
0.250
Why?
Adult
30
2024
31785
0.240
Why?
Inappropriate Prescribing
2
2015
36
0.240
Why?
Ethical Review
1
2005
3
0.240
Why?
Drug Therapy, Combination
6
2025
1193
0.240
Why?
Analgesics, Opioid
3
2019
457
0.230
Why?
Ethics Committees, Research
1
2005
33
0.230
Why?
Hospitalization
10
2012
1892
0.230
Why?
Diabetic Angiopathies
1
2005
72
0.230
Why?
Cross Infection
2
2020
332
0.230
Why?
Human Experimentation
1
2005
36
0.230
Why?
Medicaid
5
2025
254
0.230
Why?
Fingolimod Hydrochloride
2
2023
37
0.230
Why?
Opiate Substitution Treatment
1
2024
30
0.230
Why?
Internationality
3
2009
138
0.230
Why?
Alzheimer Disease
3
2022
875
0.230
Why?
Outpatients
1
2006
267
0.220
Why?
Drug Prescriptions
3
2019
237
0.220
Why?
Methadone
1
2024
126
0.220
Why?
Obesity
2
2015
2409
0.220
Why?
Polypharmacy
3
2019
39
0.220
Why?
Smoking Cessation
2
2016
209
0.220
Why?
Homes for the Aged
4
2017
25
0.220
Why?
Focus Groups
1
2024
211
0.210
Why?
Workload
1
2005
151
0.210
Why?
Cognitive Dysfunction
2
2019
312
0.210
Why?
Psychotic Disorders
3
2010
149
0.210
Why?
Education, Pharmacy
1
2024
61
0.200
Why?
Cyclin-Dependent Kinase 6
1
2023
50
0.200
Why?
Decision Making
4
2009
698
0.200
Why?
Diabetes Mellitus, Type 1
2
2010
868
0.190
Why?
Benzodiazepines
4
2017
110
0.190
Why?
Parkinson Disease
2
2020
734
0.190
Why?
Surgery Department, Hospital
1
2002
22
0.190
Why?
Postmenopause
1
2022
154
0.180
Why?
Cross-Sectional Studies
9
2020
3733
0.180
Why?
Hospital Mortality
3
2015
1088
0.180
Why?
Opioid-Related Disorders
1
2024
282
0.180
Why?
Medication Errors
2
2015
206
0.180
Why?
Biological Products
1
2023
137
0.180
Why?
Drug Interactions
2
2019
261
0.180
Why?
Kaplan-Meier Estimate
2
2023
1139
0.180
Why?
Health Status
3
2016
412
0.170
Why?
Patient Reported Outcome Measures
2
2020
204
0.170
Why?
Muscarinic Antagonists
4
2021
38
0.170
Why?
Chlorhexidine
2
2020
47
0.170
Why?
Depressive Disorder
3
2015
486
0.170
Why?
Intensive Care Units
4
2020
537
0.170
Why?
Cognition
2
2015
816
0.170
Why?
Health Maintenance Organizations
3
2009
24
0.170
Why?
Decision Support Techniques
2
2016
318
0.170
Why?
Psychotropic Drugs
2
2019
130
0.160
Why?
Advisory Committees
2
2011
158
0.160
Why?
Health Care Costs
1
2003
406
0.160
Why?
Chronic Disease
2
2016
1253
0.160
Why?
Health Services Accessibility
1
2024
649
0.150
Why?
Electronic Health Records
2
2020
792
0.150
Why?
Deprescriptions
1
2019
12
0.150
Why?
Lipids
1
2022
567
0.150
Why?
Patient Readmission
4
2016
414
0.150
Why?
Pharmacy Service, Hospital
1
2019
54
0.150
Why?
Models, Statistical
3
2015
505
0.150
Why?
Information Storage and Retrieval
1
2019
64
0.150
Why?
Drug Industry
1
2018
48
0.140
Why?
Peptic Ulcer
1
2019
151
0.140
Why?
Coronary Artery Bypass
1
2002
532
0.140
Why?
Health Services Research
3
2002
189
0.140
Why?
Diabetes Complications
4
2010
207
0.140
Why?
Texas
7
2023
3691
0.140
Why?
Prescription Drug Misuse
1
2017
9
0.140
Why?
Drug Costs
1
2018
66
0.140
Why?
Controlled Substances
1
2017
12
0.140
Why?
Health Policy
2
2009
232
0.130
Why?
Patient Discharge
4
2016
517
0.130
Why?
Prospective Studies
9
2019
6570
0.130
Why?
Patient Discharge Summaries
1
2016
9
0.130
Why?
Medication Therapy Management
1
2016
25
0.130
Why?
Age Factors
6
2015
2984
0.130
Why?
Regression Analysis
2
2009
825
0.130
Why?
Critical Care
2
2020
693
0.120
Why?
Dopamine Uptake Inhibitors
1
2015
37
0.120
Why?
Nicotinic Agonists
1
2015
45
0.120
Why?
Anti-Bacterial Agents
2
2020
2509
0.120
Why?
Southeastern United States
2
2006
40
0.120
Why?
Hip Fractures
1
2016
74
0.120
Why?
Tobacco Use Disorder
1
2016
98
0.120
Why?
Health Services Administration
2
2005
11
0.120
Why?
Diagnosis-Related Groups
1
1995
27
0.120
Why?
Palliative Care
1
2019
461
0.120
Why?
Physicians
2
2019
632
0.120
Why?
Hospital Information Systems
1
1995
46
0.120
Why?
Coronavirus Infections
1
2020
383
0.110
Why?
Pneumonia, Viral
1
2020
394
0.110
Why?
Methotrexate
3
2023
355
0.110
Why?
Residence Characteristics
3
2012
292
0.110
Why?
Health Services Needs and Demand
2
2015
179
0.110
Why?
Colistin
1
2014
33
0.110
Why?
Emergency Service, Hospital
3
2019
1152
0.110
Why?
Causality
2
2015
94
0.110
Why?
Lung Diseases, Obstructive
7
1999
34
0.110
Why?
Central Nervous System Stimulants
1
2014
130
0.110
Why?
Health Personnel
1
2019
540
0.110
Why?
Gram-Negative Bacterial Infections
1
2014
88
0.110
Why?
Community-Acquired Infections
1
2016
247
0.110
Why?
Health Resources
1
1995
126
0.110
Why?
Research Design
2
2011
746
0.110
Why?
Administration, Oral
3
2021
727
0.110
Why?
Prevalence
5
2017
2652
0.110
Why?
Evidence-Based Medicine
2
2009
677
0.110
Why?
Health Care Surveys
2
2012
293
0.110
Why?
Socioeconomic Factors
3
2015
920
0.100
Why?
Dementia, Vascular
2
2010
17
0.100
Why?
Weight Gain
1
2016
411
0.100
Why?
Mortality
1
2015
262
0.100
Why?
HIV Seroprevalence
1
1992
9
0.100
Why?
Observation
2
2010
45
0.100
Why?
Anxiety Disorders
2
2009
730
0.100
Why?
Mental Disorders
2
2019
886
0.100
Why?
California
3
2006
143
0.100
Why?
Substance-Related Disorders
1
2017
489
0.100
Why?
Sterilization, Tubal
1
1992
17
0.100
Why?
Pandemics
1
2020
1189
0.100
Why?
Housing
1
2012
54
0.100
Why?
Galantamine
2
2022
11
0.100
Why?
Rivastigmine
2
2022
18
0.100
Why?
Blood Vessels
1
2012
108
0.100
Why?
Nonlinear Dynamics
1
2012
53
0.100
Why?
Quality Assurance, Health Care
3
2007
222
0.100
Why?
Sex Factors
2
2015
1382
0.090
Why?
Phenylcarbamates
2
2022
16
0.090
Why?
Hospitals
1
1995
429
0.090
Why?
Attention Deficit Disorder with Hyperactivity
1
2014
237
0.090
Why?
Drug Therapy
2
2010
93
0.090
Why?
Models, Structural
1
2011
50
0.090
Why?
Valsartan
1
2011
23
0.090
Why?
Fosinopril
1
2011
3
0.090
Why?
Lisinopril
1
2011
23
0.090
Why?
Enalapril
1
2011
14
0.090
Why?
Captopril
1
2011
27
0.090
Why?
Reproducibility of Results
4
2016
3028
0.090
Why?
Indans
2
2022
56
0.090
Why?
Medication Systems, Hospital
1
2011
46
0.090
Why?
Adolescent
11
2023
20508
0.090
Why?
Students, Pharmacy
2
2024
71
0.090
Why?
Leg
2
2002
156
0.090
Why?
Pseudomonas Infections
1
2011
121
0.090
Why?
Nurses
1
2011
75
0.080
Why?
Blood Glucose
2
2025
1189
0.080
Why?
Pseudomonas aeruginosa
1
2011
177
0.080
Why?
Antineoplastic Agents
1
2020
1850
0.080
Why?
Predictive Value of Tests
1
2016
2294
0.080
Why?
Follow-Up Studies
6
2019
5455
0.080
Why?
Smoking
1
2015
1139
0.080
Why?
Piperidines
2
2022
239
0.080
Why?
Fee-for-Service Plans
1
2009
19
0.080
Why?
Epidemiologic Methods
1
2009
110
0.080
Why?
Cerebrovascular Disorders
1
2010
126
0.080
Why?
Young Adult
6
2024
9854
0.080
Why?
Vascular Surgical Procedures
2
2007
559
0.080
Why?
Sick Role
1
2009
32
0.080
Why?
Poverty
1
1992
434
0.080
Why?
Somatoform Disorders
1
2009
46
0.070
Why?
Insurance Coverage
1
2009
124
0.070
Why?
Cost of Illness
1
2010
275
0.070
Why?
Immunosuppressive Agents
2
2023
693
0.070
Why?
ROC Curve
1
2009
608
0.070
Why?
Bacteremia
1
2011
418
0.070
Why?
Iatrogenic Disease
2
1999
132
0.070
Why?
Kidney
1
2014
1416
0.070
Why?
Demography
2
2006
247
0.070
Why?
Quetiapine Fumarate
3
2012
17
0.070
Why?
Dibenzothiazepines
3
2012
15
0.070
Why?
Blood Vessel Prosthesis
1
2011
539
0.070
Why?
Survival Analysis
3
2009
1596
0.070
Why?
Risperidone
3
2012
60
0.060
Why?
Cyclooxygenase 2 Inhibitors
1
2006
54
0.060
Why?
Ambulatory Care
1
2009
413
0.060
Why?
Myocardial Ischemia
1
2009
365
0.060
Why?
Quality of Life
1
2016
2141
0.060
Why?
Environment
1
2006
156
0.060
Why?
Time Factors
5
2016
6570
0.060
Why?
Dogs
1
2006
798
0.060
Why?
Pulmonary Disease, Chronic Obstructive
2
2010
635
0.060
Why?
Oklahoma
1
2004
9
0.060
Why?
Evaluation Studies as Topic
1
2005
261
0.060
Why?
Academic Medical Centers
2
2016
332
0.060
Why?
National Institutes of Health (U.S.)
1
2005
140
0.060
Why?
Randomized Controlled Trials as Topic
1
2009
1210
0.060
Why?
Medical Records Systems, Computerized
1
2005
172
0.060
Why?
Hypolipidemic Agents
1
2006
187
0.050
Why?
Delivery of Health Care
1
2010
676
0.050
Why?
Narcotic Antagonists
1
2024
112
0.050
Why?
Buprenorphine
1
2024
100
0.050
Why?
Crotonates
1
2023
7
0.050
Why?
Dimethyl Fumarate
1
2023
11
0.050
Why?
Potassium Deficiency
1
2003
12
0.050
Why?
Interviews as Topic
1
2005
417
0.050
Why?
Netherlands
1
2003
47
0.050
Why?
Surgical Procedures, Operative
1
2005
190
0.050
Why?
Aortic Aneurysm, Thoracic
1
2011
678
0.050
Why?
Cross-Over Studies
1
2024
328
0.050
Why?
Cardiopulmonary Bypass
1
2005
365
0.050
Why?
Policy Making
1
2003
62
0.050
Why?
Colorectal Neoplasms
1
2009
648
0.050
Why?
Primary Health Care
1
2009
794
0.050
Why?
Pressure Ulcer
1
2003
79
0.050
Why?
Tolterodine Tartrate
1
2021
3
0.050
Why?
Surveys and Questionnaires
2
2024
3977
0.050
Why?
Linear Models
3
2016
722
0.050
Why?
Educational Measurement
1
2024
337
0.040
Why?
Acetylcholinesterase
1
2021
26
0.040
Why?
Forecasting
1
2003
376
0.040
Why?
Qualitative Research
1
2024
631
0.040
Why?
Arterial Occlusive Diseases
1
2002
128
0.040
Why?
Benchmarking
1
2002
146
0.040
Why?
Injections
1
2021
156
0.040
Why?
Hydroxychloroquine
1
2020
21
0.040
Why?
Glucocorticoids
1
2023
401
0.040
Why?
Brain
1
2012
3225
0.040
Why?
Azithromycin
1
2020
47
0.040
Why?
Soaps
1
2020
8
0.040
Why?
HIV Infections
1
1992
2068
0.040
Why?
Severity of Illness Index
3
2016
3084
0.040
Why?
Cost-Benefit Analysis
1
2003
562
0.040
Why?
Vascular Diseases
1
2001
157
0.040
Why?
Carcinoma, Hepatocellular
1
2009
1000
0.040
Why?
Pharmacists
1
2020
99
0.040
Why?
Analysis of Variance
3
2011
1044
0.040
Why?
Cancer Pain
1
2019
27
0.040
Why?
Telephone
1
2019
127
0.040
Why?
Curriculum
1
2024
772
0.040
Why?
Cholesterol, LDL
1
2022
604
0.040
Why?
Liver Neoplasms
1
2009
1411
0.040
Why?
Gift Giving
1
2018
19
0.040
Why?
Motivation
2
2018
328
0.040
Why?
Length of Stay
3
2006
1381
0.040
Why?
Conflict of Interest
1
2018
69
0.030
Why?
Program Evaluation
1
2019
455
0.030
Why?
Pain Management
1
2019
202
0.030
Why?
Isocoumarins
1
2016
2
0.030
Why?
Coumarins
1
2016
24
0.030
Why?
Betacoronavirus
1
2020
304
0.030
Why?
Antidepressive Agents
1
2019
324
0.030
Why?
Medical Records
1
1997
193
0.030
Why?
Psychiatric Status Rating Scales
2
2010
851
0.030
Why?
Pneumonia, Ventilator-Associated
1
2016
44
0.030
Why?
Renal Dialysis
1
2003
881
0.030
Why?
Disease
1
1997
133
0.030
Why?
Tertiary Care Centers
1
2016
266
0.030
Why?
Catheter-Related Infections
1
2016
104
0.030
Why?
Infection Control
1
2016
151
0.030
Why?
Geography
1
2015
124
0.030
Why?
Health Services
1
1995
73
0.030
Why?
Behavior
1
2015
75
0.030
Why?
Myocardial Revascularization
1
1995
108
0.030
Why?
Fluorouracil
1
2015
141
0.030
Why?
Health Status Indicators
1
2015
130
0.030
Why?
Bias
1
1995
147
0.030
Why?
Insurance, Health
1
1995
144
0.030
Why?
Gram-Negative Bacteria
1
2014
73
0.030
Why?
Educational Status
1
2015
293
0.030
Why?
Surgical Wound Infection
1
2016
273
0.030
Why?
Angioplasty, Balloon, Coronary
1
1995
184
0.030
Why?
Cisplatin
1
2015
287
0.030
Why?
Disease Progression
2
2010
2238
0.030
Why?
Drug Resistance, Multiple, Bacterial
1
2014
147
0.030
Why?
Registries
1
2020
1569
0.030
Why?
Chi-Square Distribution
2
2006
604
0.030
Why?
Levonorgestrel
1
1992
21
0.020
Why?
Family Planning Services
1
1992
39
0.020
Why?
APACHE
3
1999
57
0.020
Why?
Attitude
1
1992
122
0.020
Why?
Time and Motion Studies
1
2011
22
0.020
Why?
Coronary Disease
1
1995
721
0.020
Why?
Prognosis
2
2011
5074
0.020
Why?
Insurance Claim Reporting
1
2010
8
0.020
Why?
Workflow
1
2011
133
0.020
Why?
Patient Care
1
2011
100
0.020
Why?
Pulmonary Medicine
1
2010
26
0.020
Why?
Utilization Review
1
2009
40
0.020
Why?
Health Services Misuse
1
2009
28
0.020
Why?
Confidence Intervals
1
2009
300
0.020
Why?
Asthma
1
2016
813
0.020
Why?
Emergency Medical Services
1
2012
414
0.020
Why?
Sex Distribution
1
2009
330
0.020
Why?
Serotonin Antagonists
1
2008
24
0.020
Why?
Age of Onset
1
2010
636
0.020
Why?
Coronary Artery Disease
1
1995
889
0.020
Why?
Prosthesis Design
1
2011
658
0.020
Why?
Age Distribution
1
2009
444
0.020
Why?
Reference Values
1
2009
739
0.020
Why?
Drug Administration Schedule
1
2009
756
0.020
Why?
Child
2
2019
25742
0.020
Why?
Observer Variation
2
1999
312
0.020
Why?
Neuropsychological Tests
1
2010
983
0.020
Why?
Infant, Newborn
1
2019
8587
0.020
Why?
Dose-Response Relationship, Drug
1
2009
1734
0.010
Why?
Anti-Ulcer Agents
1
2005
116
0.010
Why?
Animals
1
2006
36377
0.010
Why?
Referral and Consultation
1
2009
569
0.010
Why?
Schizophrenia
1
2008
332
0.010
Why?
Clinical Trials as Topic
1
2009
1154
0.010
Why?
Liver Diseases
1
2009
390
0.010
Why?
Minimally Invasive Surgical Procedures
1
2006
194
0.010
Why?
Infant
1
2019
13162
0.010
Why?
Diagnosis, Differential
1
2009
1969
0.010
Why?
Patient Selection
1
2007
732
0.010
Why?
Mass Screening
1
2009
834
0.010
Why?
Child, Preschool
1
2019
14791
0.010
Why?
Potassium
1
2003
290
0.010
Why?
Total Quality Management
1
2001
27
0.010
Why?
Intermittent Claudication
1
2002
60
0.010
Why?
Anxiety
1
2008
999
0.010
Why?
Activities of Daily Living
1
2002
429
0.010
Why?
Southwestern United States
1
1999
48
0.010
Why?
Medical History Taking
1
1999
118
0.010
Why?
Statistics, Nonparametric
1
1999
453
0.010
Why?
Practice Guidelines as Topic
1
2005
1334
0.010
Why?
Medical Audit
1
1997
101
0.010
Why?
Facility Regulation and Control
1
1995
1
0.010
Why?
Least-Squares Analysis
1
1995
36
0.010
Why?
Kidney Failure, Chronic
1
2003
916
0.010
Why?
Medically Uninsured
1
1995
76
0.010
Why?
Cardiac Output, Low
1
1995
68
0.010
Why?
Postoperative Complications
1
2006
3155
0.010
Why?
Program Development
1
1994
190
0.010
Why?
Delphi Technique
1
1994
243
0.010
Why?
Drug Implants
1
1992
43
0.010
Why?
Condoms
1
1992
50
0.010
Why?
Delayed-Action Preparations
1
1992
125
0.010
Why?
Sensitivity and Specificity
1
1997
2161
0.010
Why?
Patient Care Team
1
1994
572
0.010
Why?
JOHNSON's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (443)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_